Keros Therapeutics, Inc.
KROS · Healthcare · $225M
$11.35+1.43%
Price
$10.88
$11.00
Jul 1, 26Sep 30, 26
What's this stock's score right now?
See its score for free — revenue and money flow, graded on one standard.
Quarterly Financials
RevenueOperating IncomeNet Income
9/'26
Revenue$15M
6/'26 vs prev quarter
Company Health
Market Cap$225M
Operating Margin-714.6%
Cash on Hand$258M114.5% of market cap
Free Cash Flow$-28M-12.4% of market cap
Among 327 Biotechnology peers
LowMedianHigh
PSR14.8xmedian 11.4xPBR0.8xmedian 2.0xROE-31.7%median -54.5%
